The world's first mRNA vaccine against a deadly disease

Published Date: 15 Mar 2023

A world first: A research team from Tel Aviv University and the Israel Institute of Biology has developed an anti-mRNA drug that is 100% effective against a single type of virus.

Read Full News

Latest News

Heat-Related Emergency Calls Vary by Region and Age

Heat-related emergency medical service activations increased in the US from 2019 to 2024, but overall emergency demand grew faster, with regional and income disparities shaping risk, a study shows.

Fewer Newborns Receive Hepatitis B Vaccination

New data show newborn hepatitis B vaccination rates have dropped, raising concern over rising misinformation.

Dry Eye Disease May Occur Years Before Autoimmune Disease

Dry eye disease affects many people across different autoimmune diseases, ranging in prevalence from about 23% to 81%, and appears about 3 years before diagnosis, a study finds.

US FDA Commissioner Makary Says FDA Supports mRNA Vaccines but US Taxpayers Should Not Bear the Cost

U.S. Food and Drug Administration Commissioner Marty Makary on Monday defended his agency's position and record on mRNA vaccines, days after it changed course and agreed to...

NIH Denies Renewal of NIAMS Director’s Contract

Criswell will reportedly stay on as an intramural scientist, continuing to investigate genetic causes of autoimmune diseases.

Omalizumab Appears Superior to Dupilumab in Urticaria

Omalizumab shows superior efficacy to dupilumab in reducing symptoms in patients with chronic spontaneous urticaria.

Todays Updates

Worsening Heart-Kidney-Metabolic Health May Threaten Vision

People with worsening cardiovascular-kidney-metabolic syndrome may face an increased risk for developing age-related macular degeneration.

Common Epilepsy Drug Tied to Increased Glaucoma Risk

Use of topiramate is linked to a higher risk for glaucoma than valproate or lamotrigine, especially in women and patients with epilepsy, new research shows.

Study Maps Extensive Disease Links Beyond Childhood Eczema

Using millions of NHS records, researchers mapped extensive links between childhood eczema and later inflammatory and eye diseases.

Beyond Skin Deep: Biologics May Benefit Eyes in Psoriasis

In patients with psoriasis, biologics may reduce ocular surface and corneal inflammation — especially dry eye, conjunctivitis, and keratitis — but they do not consistently alleviate retinal disease.

Neoadjuvant Therapy Use Rising Sharply in Cancer Care

The second annual NCDB report reveals a major shift toward preoperative systemic therapy in solid tumors, offering new opportunities for de-escalation, although careful patient selection is needed.

Two Biologics Show Comparable Benefit in Uveitis

Adalimumab and tocilizumab perform similarly in controlling inflammation while reducing the use of corticosteroids at week 16 in patients with refractory, noninfectious uveitis.

Metabolic Syndrome Tied to Glaucoma Risk

Metabolic syndrome, rather than BMI or waist circumference, is linked to an increased likelihood of glaucoma and may better identify adults who could benefit from closer eye screening.

Todays Updates

Worsening Heart-Kidney-Metabolic Health May Threaten Vision

People with worsening cardiovascular-kidney-metabolic syndrome may face an increased risk for developing age-related macular degeneration.

Common Epilepsy Drug Tied to Increased Glaucoma Risk

Use of topiramate is linked to a higher risk for glaucoma than valproate or lamotrigine, especially in women and patients with epilepsy, new research shows.

Study Maps Extensive Disease Links Beyond Childhood Eczema

Using millions of NHS records, researchers mapped extensive links between childhood eczema and later inflammatory and eye diseases.

Beyond Skin Deep: Biologics May Benefit Eyes in Psoriasis

In patients with psoriasis, biologics may reduce ocular surface and corneal inflammation — especially dry eye, conjunctivitis, and keratitis — but they do not consistently alleviate retinal disease.

Neoadjuvant Therapy Use Rising Sharply in Cancer Care

The second annual NCDB report reveals a major shift toward preoperative systemic therapy in solid tumors, offering new opportunities for de-escalation, although careful patient selection is needed.

Two Biologics Show Comparable Benefit in Uveitis

Adalimumab and tocilizumab perform similarly in controlling inflammation while reducing the use of corticosteroids at week 16 in patients with refractory, noninfectious uveitis.

Metabolic Syndrome Tied to Glaucoma Risk

Metabolic syndrome, rather than BMI or waist circumference, is linked to an increased likelihood of glaucoma and may better identify adults who could benefit from closer eye screening.

Latest News

Heat-related emergency medical service activations increased in the US from 2019 to 2024, but overall emergency demand grew faster, with regional and income disparities shaping risk, a study shows.

New data show newborn hepatitis B vaccination rates have dropped, raising concern over rising misinformation.

Dry eye disease affects many people across different autoimmune diseases, ranging in prevalence from about 23% to 81%, and appears about 3 years before diagnosis, a study finds.

U.S. Food and Drug Administration Commissioner Marty Makary on Monday defended his agency's position and record on mRNA vaccines, days after it changed course and agreed to...

Criswell will reportedly stay on as an intramural scientist, continuing to investigate genetic causes of autoimmune diseases.

Omalizumab shows superior efficacy to dupilumab in reducing symptoms in patients with chronic spontaneous urticaria.

News All Time

Early Top-Down Therapy May Modify Course of Crohn’s Disease

Starting biologic therapy at diagnosis, rather than escalating later, may significantly reduce complications and hospitalizations in Crohn’s disease, according to new data.

FDA Approves New Topical for Atopic Dermatitis

Difamilast is the third PDE4 inhibitor approved by the FDA for treating atopic dermatitis.

Gluten Sensitivity Without Celiac Disease Common in IBS

About 30% of young adults with irritable bowel syndrome report gluten sensitivity without celiac disease or wheat allergy and improve on a gluten-free diet.

HER2 Therapy for Biliary Cancer Approved by UK Regulator

The MHRA approved a first-in-class bispecific antibody for HER2-positive biliary tract cancer, offering a new line of therapy for patients who have progressed on standard care.

Protective Clothing, Low-Cost Sunscreens May Cut Expenses

The annual cost of recommended sunscreen use varies by up to 36-fold, depending on unit price and concurrent sun-protective behaviors.

Measles Cases in South Carolina Rise by 12 to 962, State Health Department Says

South Carolina reported a surge to 962 measles cases on Tuesday, state health data showed, including ⁠12 additional infections since Friday, as officials warned the widening...

Urgent TRUE METRIX Glucose Meter Alert Updates Error Message

As currently written, the instructions could potentially lead to delayed treatment of high glucose levels.

Rural vs Urban: The Neonatal Care Divide in US Hospitals

An expansion of higher-level neonatal care has been observed in urban hospitals in the US over the years, whereas rural hospitals have faced a decline in such care capacity, per a recent study.

Systemic Inflammation in Heart Failure

A study on the prevalence and correlates of high-sensitivity C-reactive protein ≥2 mg/L. across the spectrum of HF using date from 3 major trials: SELECT, SOUL, and FLOW.

Moving the Regulatory Goalpost in Vaccine Innovation

Despite standard process and discussion between manufacturer and regulators, FDA has now declined to review an mRNA flu vaccine. Is this a turning point for mRNA vaccines?

Sulfa Allergy Delabeling May Be Safe in Adults

A single‑dose oral challenge appears safe for identifying adults with unnecessary, low‑risk sulfa antibiotic allergy labels, researchers report.

Integrated Pathway Improves Paediatric Asthma Care

A new integrated care pathway for paediatric acute asthma enhances inhaler use and key clinical documentation across primary care and ED settings without an increase in admission rates or revisits.

Statin Use Tied to Lower Hepatic Decompensation Risk in PBC

Statin use in patients with primary biliary cholangitis is linked to lower risks for hepatic decompensation and major adverse liver outcomes.

Dupilumab Improves Antihistamine-Resistant CSU

For antihistamine-resistant patients with chronic spontaneous urticaria, dupilumab improves itch and hives after 24 weeks of treatment.

High Fracture Risk Persists in Kidney Transplant Recipients

A notable proportion of kidney transplant recipients experience fractures, with rates being unchanged over 20 years and a high imminent risk for subsequent fractures seen following a first fracture.

Recommended News For You

Telehealth in the pandemic era resulted in fewer therapy interruptions.

New BiTE Agent for Small Cell Lung Cancer Approved by the FDA.

By acquiring T3 Pharma, a leader in bacterial cancer treatment, Boehringer Ingelheim broadens its offering in immunooncology.

Too Many Kids With Sickle Cell Disease Aren't Getting Appropriate Preventive Care

Pharyngoesophageal junction cancer is not a good candidate for endoscopically assisted transoral surgery.

Year in Review: Multiple Myeloma

Routine breast cancer screening can bring better outcomes for patients

Recommended Articles For You

Unlocking the Potential of Cancer Antigen 19-9 for Early Detection 

Unlocking the Mystery of Glanzmann Thrombasthenia: A New Hope for Patients 

Harnessing Snake Venom in Hematology: From Toxins to Life-Saving Therapeutics 

The Role of Calcium Corrections in Accurate Blood Test Results  

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Momelotinib, a JAK inhibitor, has FDA approval to treat adult myelofibrosis in anemic patients.

2.

Limited Benefit from New Drugs; Significant Increase in Drug Prices; AI Boost for Mammo Results.

3.

Study Supports Lactated Ringer Solution for Fluid Resuscitation in SCD

4.

Cancer mortality continuing to decline, says report

5.

Targeted radiation offers promise in patients with metastasized small cell lung cancer to the brain

1.

Unmasking the Subtle Symptoms of Colon Cancer

2.

Priming Agents: A Novel Approach to Enhancing Cell-Free DNA Detection in Liquid Biopsies

3.

The Basics of M.C.V Normal Range for Better Health Management

4.

How Prevident is Revolutionizing Oral Care

5.

Future of Chemotherapy: New Advances, Treatments & Survival Rates Transforming Cancer Care

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Navigating the Complexities of Ph Negative ALL - Part XV

2.

Newer Immunotherapies for Myeloma- A Comprehensive Overview

3.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part III

4.

Efficient Management of First line ALK-rearranged NSCLC

5.

Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot